Opticann, a division of Heritage Cannabis, was founded by pioneers in the medical cannabis space who come from the healthcare and pharmaceutical industries. Established by former MedReleaf and Cynapsus Therapeutics executives, Opticann’s pharmaceutical-focused team has 40 years’ combined experience in the pharmaceutical industry and over 20 years of experience in clinical medicine and medical cannabis product development.
Many medical patients and their health care practitioners are still developing their understanding of the therapeutic potential of cannabinoids for improving peoples’ lives. Our goal is to help accelerate this education and provide the most effective products based on scientific evidence and innovative technology.
Opticann’s suite of medical cannabis products are based on trusted pharmaceutical technology platforms that are proven to enhance performance of products–for rapid and maximum effect–while minimizing unwanted effects.
Our product formats may be familiar to most medical patients: oral capsules, sublingual filmstrips, and topically administered products in the form of gels and creams. All Opticann products are based on innovative pharmaceutical technology that deliver results consistently, safely, and in convenient dosage forms. These dosage forms are clinically tested and optimized to deliver active ingredients for effective results.
Our promise to all patients: